25 Nov, EOD - Indian

SENSEX 80109.85 (1.25)

Nifty 50 24221.9 (1.32)

Nifty Bank 52207.5 (2.10)

Nifty IT 43618.15 (0.66)

Nifty Midcap 100 55900.55 (1.61)

Nifty Next 50 69342.7 (1.95)

Nifty Pharma 22177.05 (0.98)

Nifty Smallcap 100 18115.85 (2.03)

25 Nov, EOD - Global

NIKKEI 225 38780.14 (1.30)

HANG SENG 19150.99 (-0.41)

S&P 6024.25 (0.42)

LOGIN HERE

Medplus Health Services Ltd

You are Here : Home > Markets > CompanyInformation > Company Background
BSE Code : 543427 | NSE Symbol : MEDPLUS | ISIN : INE804L01022 | Industry : Retail |


Chairman's Speech

As we reflect on the past eighteen years, we can proudly acknowledge the strides we have taken in delivering value to all stakeholders. Our reach now extends to over 640 cities across Telangana, Andhra Pradesh, Karnataka, Tamil Nadu, West Bengal, Orissa, Maharashtra, Madhya Pradesh, Chhattisgarh and Kerala.

While our success story in the pharmaceutical retail sector continues to unfold, we recognise the potential of exploring new horizons. During the year, your Company has launched ‘MedPlus? branded pharmaceutical products in several therapeutic areas covering acute and chronic ailments. This is in line with our core principle of offering quality and affordable medicines to our valued customers. We get these medicines manufactured in the same factories that cater to the needs of large pharmaceutical companies in the country, ensuring product quality and genuine medicines. For the year, the revenues from these products amounted to Rs 7,477.35 million on a GMV basis (#Gross Merchandising Value). This represented 10.70% of our Pharmacy Revenues on a GMV basis and 8.31% on Net Reported Revenues. We are happy to report that this has contributed to significant savings for our valued customers.

#GMV=MRP-GST

The organised retail in the pharmacy and wellness category (which includes organised brick- and-mortar stores as well as E-commerce) was approximately 18% in FY 2023 in the total retail pharmacy and wellness category and is expected to increase to approximately 23% by FY 2027, implying a CAGR of ~19% between FY 2023 and FY 2027.

In the case of retail pharmacy, space requirements and unit economics are favourable to a neighbourhood store location, and advantages of range, discount, technology, and professional approach make modern pharmacy successful.

The key market characteristics of the domestic pharmaceutical market include low per capita health expenditure, a high share of private out-of-pocket expenses (which includes purchases from pharmacies), lower penetration across rural areas and a growing trend of private sector-led integrated approach to treatment. The sector has a high opportunity for growth, given the limited penetration of health services both in rural and urban areas. There are gaps across awareness, access, affordability and acceptability of products and services

During the financial year:

• We registered Rs 56,248.55 million in revenue from operations in 2023-24, recording a 23.42% growth as compared to the previous year?s revenue of Rs45,575.76 million.

• Our EBITDA stood at Rs 3,940.90 million in 2023-24, compared to the previous year when it stood at Rs 3,117.46 million.

As we navigate the future, we remain committed to our core values, the pursuit of excellence, and our mission of enhancing healthcare accessibility and affordability.

Your Company continues to focus on providing pharmaceuticals, wellness items and fast-moving consumer goods guided by the three core principles:

• Providing genuine products

• Offering unparalleled convenience to all consumers (with our omnichannel model) and

• Ensuring superior storage conditions all while maintaining competitive pricing.

Through our unwavering dedication, we are poised to continue making a positive impact on the lives of countless individuals and the larger healthcare ecosystem.

I am truly touched and thankful to each and every individual who has entrusted us with their well-being. Serving as your companion on this transformative journey towards improved health and wellness is a privilege that I deeply cherish.

To the distinguished members of our Board, I want to express my profound gratitude for their enduring trust and unwavering support. Your guidance has been the cornerstone of our progress, and your belief in our mission has been instrumental in propelling us forward.

I extend my heartfelt appreciation to our esteemed shareholders, whose unwavering faith in our vision has been a driving force behind our accomplishments. Your confidence empowers us to push the boundaries of healthcare delivery and set new benchmarks for excellence.

Our achievements would not be possible without our dedicated employees. I thank you for your passion and commitment.

In embracing the challenges and opportunities that lie ahead, let us stand united, bound by our shared vision and the unwavering support that has brought us this far. With a heart full of gratitude, I look forward to the continued journey of elevating healthcare and enriching lives together.

Thanks,

Gangadi Madhukar Reddy

Chairman, MD & CEO